The potential of using artificial intelligence in drug discovery and development has sparked both excitement…
PHARMA & CLINICAL TRIALS
UC Riverside scientists have developed a nanopore-based tool that could help diagnose illnesses much faster…
A drug recently approved to prevent migraine may start working right away, according to a…
Phase 1/2 of the clinical trial shows that the administration of the AEF0217 molecule developed…
PDE6b-related Retinitis Pigmentosa is a rare inherited retinal dystrophy affecting up to 3,000 people in the…
Preclinical study suggests the compound could restore lost muscle for patients with the rare degenerative…
Mayo Clinic announces the results of an innovative treatment approach that may offer improvement in overall…
The first time a breathing rhythm in the human hippocampus found during sleep Breathing is…
Team members from Kessler Foundation and Kessler Institute for Rehabilitation, a Select Medical hospital, will participate in an…
Petrovax announced today the positive results from “Long-CoV-III-21,” a randomized, double-blind, placebo-controlled trial evaluating the…
